PROTHENA CORPORATION PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.87 USD | +1.51% |
|
-1.37% | -42.57% |
| Mar. 04 | Prothena Names David Ford as Chief People Officer | MT |
| Mar. 04 | Prothena Appoints David Ford to Newly Created Chief People Officer | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 631.6 | 479.5 | 2,302 | 3,111 | 1,950 | 1,121 | - | - |
| Enterprise Value (EV) 1 | 631.6 | 479.5 | 2,302 | 3,111 | 1,331 | 498.2 | 563 | 1,121 |
| P/E ratio | -8.12 x | -4.32 x | 35.8 x | -24.4 x | -13.2 x | -4.34 x | -5.38 x | -7.93 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 776 x | 562 x | 11.5 x | 57.7 x | 21.3 x | 83.9 x | 9.52 x | 4.92 x |
| EV / Revenue | 776 x | 562 x | 11.5 x | 57.7 x | 14.6 x | 37.3 x | 4.78 x | 4.92 x |
| EV / EBITDA | - | -4.31 x | 31.5 x | - | -7 x | -1.21 x | -1.29 x | - |
| EV / FCF | -11.7 x | -5.95 x | 25 x | - | -9.74 x | -2.17 x | -33.3 x | -9.98 x |
| FCF Yield | -8.56% | -16.8% | 4% | - | -10.3% | -46.1% | -3% | -10% |
| Price to Book | - | - | - | - | 3.44 x | - | - | - |
| Nbr of stocks (in thousands) | 39,897 | 39,921 | 46,594 | 51,627 | 53,665 | 53,720 | - | - |
| Reference price 2 | 15.83 | 12.01 | 49.40 | 60.25 | 36.34 | 20.87 | 20.87 | 20.87 |
| Announcement Date | 2/12/20 | 2/11/21 | 2/17/22 | 2/23/23 | 2/15/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 0.814 | 0.853 | 200.6 | 53.9 | 91.37 | 13.36 | 117.8 | 228 |
| EBITDA 1 | - | -111.2 | 73.09 | - | -190.1 | -411 | -437.1 | - |
| EBIT 1 | -85.7 | -112.7 | 71.98 | -131.6 | -191 | -298.6 | -278.5 | -126.6 |
| Operating Margin | -10,527.89% | -13,216.18% | 35.88% | -244.05% | -209.08% | -2,235.93% | -236.48% | -55.53% |
| Earnings before Tax (EBT) 1 | -77.3 | -111.4 | 71.92 | -125.6 | -160.5 | -283.1 | -278.2 | -128.6 |
| Net income 1 | -77.68 | -111.1 | 66.98 | -116.9 | -147 | -261.8 | -219.6 | -150.5 |
| Net margin | -9,542.63% | -13,029.78% | 33.39% | -216.95% | -160.91% | -1,960.35% | -186.42% | -66.01% |
| EPS 2 | -1.950 | -2.780 | 1.380 | -2.470 | -2.760 | -4.805 | -3.881 | -2.632 |
| Free Cash Flow 1 | -54.06 | -80.56 | 92.03 | - | -136.7 | -229.4 | -16.88 | -112.3 |
| FCF margin | -6,641.65% | -9,444.08% | 45.88% | - | -149.63% | -1,718% | -14.34% | -49.25% |
| FCF Conversion (EBITDA) | - | - | 125.91% | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | 137.41% | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Announcement Date | 2/12/20 | 2/11/21 | 2/17/22 | 2/23/23 | 2/15/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 139.2 | 1.172 | 1.153 | 1.312 | 1.517 | 49.92 | 2.169 | 4.019 | 84.87 | 0.316 | 2.166 | 2.166 | 2.166 | 8.416 | - |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | 109.2 | -33.09 | -37.94 | -43.21 | -50.33 | -0.072 | -56.32 | -66.5 | 10.31 | -78.52 | -73.22 | -73.67 | -74.94 | -76.27 | -75.06 |
| Operating Margin | 78.48% | -2,823.55% | -3,290.89% | -3,293.37% | -3,317.86% | -0.14% | -2,596.82% | -1,654.74% | 12.15% | -24,846.52% | -3,381.38% | -3,402.02% | -3,460.67% | -906.25% | - |
| Earnings before Tax (EBT) 1 | 109.2 | -33.1 | -37.96 | -42.57 | -48.42 | 3.345 | -49.78 | -58.9 | 18.82 | -70.62 | -69.43 | -69.77 | -71.68 | -74.71 | -83.13 |
| Net income 1 | 109.2 | -33.18 | -36.29 | -41.24 | -45.76 | 6.349 | -46.86 | -54.6 | 21.91 | -67.48 | -65.28 | -66.03 | -67.72 | -69.69 | -75.31 |
| Net margin | 78.5% | -2,830.97% | -3,147.44% | -3,143.6% | -3,016.74% | 12.72% | -2,160.63% | -1,358.42% | 25.81% | -21,353.16% | -3,014.74% | -3,049.18% | -3,127.45% | -828.12% | - |
| EPS 2 | 2.130 | -0.7100 | -0.7800 | -0.8800 | -0.9700 | 0.1200 | -0.8900 | -1.030 | 0.3800 | -1.260 | -1.218 | -1.225 | -1.253 | -1.298 | -1.345 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/4/21 | 2/17/22 | 5/5/22 | 8/8/22 | 11/3/22 | 2/23/23 | 5/4/23 | 8/3/23 | 11/2/23 | 2/15/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | - | - | - | - | 619 | 623 | 558 | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | -54.1 | -80.6 | 92 | - | -137 | -229 | -16.9 | -112 |
| ROE (net income / shareholders' equity) | -26.1% | -48.6% | 20.6% | -21.5% | -24.8% | -57.2% | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | -20.2% | - | - | - |
| Assets 1 | - | - | - | - | 727.2 | - | - | - |
| Book Value Per Share | - | - | - | - | 10.50 | - | - | - |
| Cash Flow per Share 2 | -1.330 | -2.010 | 1.910 | - | -2.520 | -3.610 | -5.150 | - |
| Capex 1 | 0.56 | 0.2 | 0.58 | - | 2.81 | 0.35 | 0.38 | 0.59 |
| Capex / Sales | 68.18% | 22.98% | 0.29% | - | 3.08% | 2.64% | 0.33% | 0.26% |
| Announcement Date | 2/12/20 | 2/11/21 | 2/17/22 | 2/23/23 | 2/15/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
20.87
USD
Average target price
66.09
USD
Spread / Average Target
+216.67%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -42.57% | 1.12B | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.73B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
- Stock Market
- Equities
- PRTA Stock
- Financials Prothena Corporation plc
